Genetic screening of brain metastases could reveal new targets for treatment

NETTER-1: Targeted radionuclide therapy improves PFS in mid-gut NETs

RADIANT-4: Results of international trial show promise in the treatment of neuroendocrine tumours

Mid-gut NETs respond to targeted radionuclide therapy: NETTER-1 results

Comment: EUROCARE-5, large blood cancer survival differences throughout Europe

Comment: New immunotherapy options for kidney cancer

Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries

Large variations found in survival from blood cancers between European countries

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer

Everolimus for non-functional neuroendocrine tumours

Nivolumab improves overall survival for advanced kidney cancer

EUROCARE-5 results show large variations in survival from blood cancers between European countries